Building National Brand and Product Portfolio
COMPANY OVERVIEW
Optimizing Scale, Improving Efficiency and Growing Profitability Across Strategic National Platform
94
US Retail Locations (1)
31
US Cultivation &
Manufacturing Facilities
血
16
Jurisdictions in
US
4)
7232
1)
2)
3)
$35B+
2027 TAM in Licensed
US States (2)
+2M
Sqft Cultivation &
Production Capacity(3)
$
2
P
$125M
Q1 2023 Revenue
150+
Acres Outdoor
Cultivation Capacity(3)
1%
YoY Topline Revenue
Growth in Q1 2023
VE
38%
Q1 2023 Adj. Gross
Margin (4)
Pro forma facilities either open or under development. Does not include non-operational retail locations as of May 15, 2023
Estimated Sales figures from BDSA Market Forecast as of February 2023, broker research, company estimates
Total capacity under existing licenses - additional development may be required to achieve
Non-GAAP figure. See "Non-GAAP Financial Measures" on previous slides
6
Columbia Care™View entire presentation